Yueyang Xinhuada Biological Vaccine Co., Ltd.


The company has complete production equipment, excellent testing instruments, active scientific research and academic research, advanced technology and scientific management process. At present, the company has GMP-certified production lines for tablets, capsules, granules, external solutions, oral solutions, suppositories, ointments, etc. The production lines under construction and improvement include freeze-drying workshop, sub-packaging workshop, small water needle workshop, traditional Chinese medicine extraction workshop and chemical synthesis workshop. The company's products have advanced production technology, perfect quality control methods, and high technology content. The sales outlets have spread across more than 30 provinces, municipalities and autonomous regions across the country.
    
Companies in accordance with the modern enterprise system and full GMP management mode of operation, the implementation of flat management. The functional departments are set up as "three departments and two centers" such as production department, quality department, management department, marketing center and drug research and development center. The five departments all implement the general manager responsibility system under the leadership of the board of directors. The members of the company's board of directors are also experienced entrepreneurs, experienced marketing experts or experienced innovative drug experts; among the employees, those with doctor's degree, master's degree, bachelor's degree or above account for more than 70% of the total number. The company's sales revenue has doubled for three consecutive years, product research and development has developed steadily from imitation to innovative drugs, and corporate profits and employee benefits have increased year by year.
   
As a scientific research-oriented, innovative drug pharmaceutical company dedicated to research, development and sales with independent intellectual property rights, the company adheres to the product research and development strategy of "production while research and development"; actively learns from advanced science and technology at home and abroad, and pays attention to relevant domestic and foreign The technical cooperation and exchange of scientific research institutions and famous universities; the use of a series of new technologies such as slow release, controlled release, gene cloning and gene recombination, constantly update, occupy the technological high ground in chemicals and biomedicine. The company follows the trend of pharmaceutical development at home and abroad, focuses on market hotspots, and gives priority to the development of genetically engineered drugs, vaccines and antibody drugs for the treatment of tumors, immune diseases, infectious diseases and cardiovascular diseases. strive to provide safe, effective and cost-effective innovative drugs for the company's users.
    
We value talent, people-oriented, and strive to build the company into a dedication to knowledge, tap potential, show talent, so as to achieve self-worth and create wealth platform. Strive to become a cradle of cultivating talents for society, creating value for all mankind, and containing humanistic care. The responsibility of our enterprise lies in the continuous development of valuable drugs for the health of all mankind, the courage to explore and innovate, constantly surpass ourselves, and work hand in hand with colleagues in the medical field to compose a new poem for the cause of human medicine!